Quarterly report [Sections 13 or 15(d)]

NON CONTROLLING INTEREST (Details)

v3.25.1
NON CONTROLLING INTEREST (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net loss attributable to the non-controlling interest $ (10,357) $ (687)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss $ (42,784) $ (1,549)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (10,354) $ (375)
Joseph DeSanto MD [Member]    
Net loss $ (10) $ (892)
Average Non-controlling interest percentage of profit/losses 35.00% 35.00%
Net loss attributable to the non-controlling interest $ (3) $ (312)